The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 21, 2015, Pages 6694-6699

  Hellert, Jan ^a   Weidner Glunde, Magdalena ^b   Krausze, Joern ^a   Lünsdorf, Heinrich ^a   Ritter, Christiane ^a   Schulz, Thomas F ^b   Lührs, Thorsten ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

DNA binding protein; Gammaherpesvirinae; KSHV LANA; Viral latency; X ray crystallography

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; LATENCY ASSOCIATED NUCLEAR ANTIGEN; DNA BINDING PROTEIN; LATENCY-ASSOCIATED NUCLEAR ANTIGEN; NUCLEAR PROTEIN; VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; DNA CONFORMATION; DNA SEQUENCE; ELECTRON MICROSCOPY; GEL MOBILITY SHIFT ASSAY; HERPESVIRIDAE; ISOTHERMAL TITRATION CALORIMETRY; KAPOSI SARCOMA; NONHUMAN; OLIGOMERIZATION; PLEIOTROPY; PRIORITY JOURNAL; VIRUS GENOME; VIRUS REPLICATION; X RAY CRYSTALLOGRAPHY; AMINO ACID SEQUENCE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; HUMAN HERPESVIRUS 8; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; SMALL ANGLE SCATTERING; STATIC ELECTRICITY; X RAY DIFFRACTION;

GAMMAHERPESVIRINAE; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; LANA;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BASE SEQUENCE; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DNA, VIRAL; DNA-BINDING PROTEINS; HERPESVIRUS 8, HUMAN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; SCATTERING, SMALL ANGLE; STATIC ELECTRICITY; X-RAY DIFFRACTION;

EID: 84930221628     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1421804112     Document Type: Article

References (44)

1. Schulz TF (2006) The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 208(2):187-198.
2. Chang Y, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.Science 266(5192):1865-1869.
3. Ballestas ME, Kaye KM (2011) The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol 6(12):1399-1413.
4. Verma SC, Lan K, Robertson E (2007) Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol 312:101-136.
5. Rainbow L, et al. (1997) The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71(8):5915-5921.
6. Kedes DH, Lagunoff M, Renne R, Ganem D (1997) Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100(10):2606-2610.
7. Dosztányi Z, Csizmok V, Tompa P, Simon I (2005) IUPred: Web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics 21(16):3433-3434.
8. Hellert J, et al. (2013) A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins. PLoS Pathog 9(10):e1003640.
9. Domsic JF, Chen HS, Lu F, Marmorstein R, Lieberman PM (2013) Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA. PLoS Pathog 9(10):e1003672.
10. Garber AC, Hu J, Renne R (2002) Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem 277(30):27401-27411.
11. Kelley-Clarke B, et al. (2007) Determination of Kaposi's sarcoma-associated herpes-virus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding. J Virol 81(8):4348-4356.
12. Barbera AJ, et al. (2006) The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311(5762):856-861.
13. Bochkarev A, et al. (1996) Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84(5):791-800.
14. Hegde RS, Grossman SR, Laimins LA, Sigler PB (1992) Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359(6395):505-512.
15. Han SJ, Hu J, Pierce B, Weng Z, Renne R (2010) Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins. J Gen Virol 91(Pt 9):2203-2215.
16. Hellert J, Krausze J, Schulz TF, Lührs T (2014) Crystallization, room-temperature X-ray diffraction and preliminary analysis of Kaposi's sarcoma herpesvirus LANA bound to DNA. Acta Crystallogr F Struct Biol Commun 70(Pt 11):1570-1574.
17. Srinivasan V, Komatsu T, Ballestas ME, Kaye KM (2004) Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNA. J Virol 78(24):14033-14038.
18. Tolstorukov MY, Jernigan RL, Zhurkin VB (2004) Protein-DNA hydrophobic recognition in the minor groove is facilitated by sugar switching. J Mol Biol 337(1):65-76.
19. Rohs R, et al. (2009) The role of DNA shape in protein-DNA recognition. Nature 461(7268):1248-1253.
20. Wong LY, Wilson AC (2005) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. J Virol 79(21):13829-13836.
21. Hu J, Renne R (2005) Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol 79(4):2637-2642.
22. Hu J, Garber AC, Renne R (2002) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76(22):11677-11687.
23. Ballestas ME, Chatis PA, Kaye KM (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284(5414):641-644.
24. Renne R, et al. (2001) Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75(1):458-468.
25. Gao SJ, et al. (1996) KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2(8):925-928.
26. Simpson GR, et al. (1996) Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348(9035):1133-1138.
27. Kedes DH, et al. (1996) The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2(8):918-924.
28. Kaul R, Verma SC, Robertson ES (2007) Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. Virology 364(2):317-329.
29. Mercier A, Arias C, Madrid AS, Holdorf MM, Ganem D (2014) Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation. J Virol 88(12):6762-6777.
30. Hu J, et al. (2014) LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex. PLoS Pathog 10(7):e1004240.
31. Sun J, et al. (2013) Cryo-EM structure of a helicase loading intermediate containing ORC-Cdc6-Cdt1-MCM2-7 bound to DNA. Nat Struct Mol Biol 20(8):944-951.
32. Bowman GD, O'Donnell M, Kuriyan J (2004) Structural analysis of a eukaryotic sliding DNA clamp-clamp loader complex. Nature 429(6993):724-730.
33. Lim C, Sohn H, Lee D, Gwack Y, Choe J (2002) Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J Virol 76(20):10320-10331.
34. Verma SC, Choudhuri T, Kaul R, Robertson ES (2006) Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J Virol 80(5):2243-2256.
35. Sun Q, et al. (2014) Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence. Proc Natl Acad Sci USA 111(32):11816-11821.
36. Verma SC, et al. (2011) Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication. PLoS Pathog 7(11):e1002365.
37. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66(Pt 4):486-501.
38. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66(Pt 2):213-221.
39. Mueller U, et al. (2012) Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin. J Synchrotron Radiat 19(Pt 3):442-449.
40. Kabsch W (2010) Xds. Acta Crystallogr D Biol Crystallogr 66(Pt 2):125-132.
41. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53(Pt 3):240-255.
42. van Dijk M, Bonvin AM (2009) 3D-DART: A DNA structure modelling server. Nucleic Acids Res 37(web server issue):W235-W239.
43. Grundhoff A, Ganem D (2003) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J Virol 77(4):2779-2783.
44. Lagunoff M, Ganem D (1997) The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236(1):147-154.